As part of the new Pharmacy Code (ApBetrO), the states want clear definitions of what constitutes an infringement in the production of blister packs and parenterals.
As a basic principle, any pharmacy who produces blister packs for individual patients has to have a functioning QM-system in place. In implementing the new rules, the health committee of the Federal Council of Germany now wants any violations to be dealt with specifically as infringements.
The Federal Association of Pharmacies Supplying Hospitals and Nursing Homes (BVKA) does not deem it necessary to expand any further on the infringements in the Pharmacy Code: The list was not conclusive and was already offering sufficient opportunities to the relevant authorities for imposing penalties.
[ilink url=http://www.apotheke-adhoc.de/nachrichten/apothekenpraxis/bussgelder-fuer-blister-und-zyto-apotheken] link to source (apotheke-adhoc)[/ilink]